Healthcare
Regeneron Pharmaceuticals, Inc. (REGN)
45/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $74.2B
- P/E
- 17.0
- Sector Median P/E
- 20.7
- F-Score
- 5/9
- ROIC
- 1.5%
- FCF Yield
- 5.6%
REGN has a Tessera Quality Score of 44, placing it in the top 50% of the Healthcare sector. Its P/E of 17.0 is 18% below the Healthcare sector median (20.7). Piotroski F-Score is 5/9; trailing ROIC is 1.5%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $109.1B · FCF: 30.3%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- argenx SE (ARGX)Mkt Cap: $49.7B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%
- Alnylam Pharmaceuticals, Inc. (ALNY)Mkt Cap: $38.9B · FCF: 15.0%